Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis
- PMID: 27331014
- PMCID: PMC4908280
- DOI: 10.1016/j.mgene.2016.04.004
Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis
Abstract
Background: It has been reported that three common loci, SstI, C-482T, and T-455C, in the apolipoprotein C3 (APOC3) gene might be associated with an increased risk of coronary heart disease (CHD). Considering the inconsistent results and ethnicity variations, we performed a systematic meta-analysis to evaluate the association between three single nucleotide polymorphisms (SNPs) and the risk of CHD.
Methods: We searched HuGE Navigator and PubMed databases to screen for the related literature published before 25 September, 2015. Two independent reviewers extracted the data and assessed the study quality. A random-effect model was used to pool the effect size.
Results: A total of 29 studies met inclusion criteria. Nineteen studies, including 11,186 subjects relative to SstI, five studies comprising 3727 subjects relative to C-482T, and nine studies with 6753 subjects relative to T-455C were included in the final analysis. A significant increase in CHD risk was observed in the SstI polymorphism (S2 versus S1: odds ratio [OR] = 1.30, 95% confidence interval [CI] 1.10-1.55. There was also a significant increasing trend of CHD risk in the T-455C polymorphism (C versus T: OR = 1.28, 95% CI 1.16-1.41. However, no associations between C-482T and CHD risk were found in this meta-analysis.
Conclusions: The pooled evidence suggests that two SNPs (SstI and T-455C) are associated with an increased risk of CHD. However, because of the limited sample size and heterogeneity, further large-scale and well-designed studies are needed to validate our findings.
Keywords: Apolipoprotein C3; Coronary heart disease; Meta-analysis.
Figures
Similar articles
-
Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.Aging Dis. 2016 Jan 2;7(1):36-44. doi: 10.14336/AD.2015.0709. eCollection 2016 Jan. Aging Dis. 2016. PMID: 26816662 Free PMC article.
-
Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.Lipids Health Dis. 2011 Nov 4;10:200. doi: 10.1186/1476-511X-10-200. Lipids Health Dis. 2011. PMID: 22054125 Free PMC article.
-
APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.Arch Med Res. 2007 May;38(4):444-51. doi: 10.1016/j.arcmed.2006.10.013. Epub 2007 Mar 26. Arch Med Res. 2007. PMID: 17416293 Free PMC article.
-
The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.Wien Klin Wochenschr. 2012 Oct;124(19-20):671-7. doi: 10.1007/s00508-012-0223-0. Epub 2012 Sep 18. Wien Klin Wochenschr. 2012. PMID: 22987045 Review.
-
APRISMA-compliant systematic review and meta-analysis determining the association of miRNA polymorphisms and risk of congenital heart disease.Medicine (Baltimore). 2019 Nov;98(45):e17653. doi: 10.1097/MD.0000000000017653. Medicine (Baltimore). 2019. PMID: 31702616 Free PMC article.
Cited by
-
Genetic Polymorphisms and Genetic Risk Scores Contribute to the Risk of Coronary Artery Disease (CAD) in a North Indian Population.Int J Mol Sci. 2024 Aug 5;25(15):8552. doi: 10.3390/ijms25158552. Int J Mol Sci. 2024. PMID: 39126122 Free PMC article.
-
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups.Lipids Health Dis. 2021 Sep 21;20(1):113. doi: 10.1186/s12944-021-01531-8. Lipids Health Dis. 2021. PMID: 34548093 Free PMC article.
-
Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update.Ann Nutr Metab. 2017;70(1):26-33. doi: 10.1159/000455681. Epub 2017 Jan 27. Ann Nutr Metab. 2017. PMID: 28125802 Free PMC article.
-
SNPs in apolipoproteins contribute to sex-dependent differences in blood lipids before and after a high-fat dietary challenge in healthy U.S. adults.BMC Nutr. 2022 Sep 1;8(1):95. doi: 10.1186/s40795-022-00592-x. BMC Nutr. 2022. PMID: 36050800 Free PMC article.
-
Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.Lipids Health Dis. 2017 Nov 13;16(1):213. doi: 10.1186/s12944-017-0607-2. Lipids Health Dis. 2017. PMID: 29132372 Free PMC article.
References
-
- Abdel-Maksoud M.F., Hokanson J.E. The complex role of triglycerides in cardiovascular disease. Semin. Vasc. Med. 2002;2:325–333. - PubMed
-
- Brown W.V., Baginsky M.L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem. Biophys. Res. Commun. 1972;46:375–382. - PubMed
-
- Bruns G.A., Karathanasis S.K., Breslow J.L. Human apolipoprotein A-I–C-III gene complex is located on chromosome 11. Arteriosclerosis. 1984;4:97–102. - PubMed
-
- Coban N., Onat A., Guclu-Geyik F., Komurcu-Bayrak E., Sansoy V., Hergenc G., Can G., Erginel-Unaltuna N. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) − 482C > T polymorphism on triglyceride concentration in Turkish adults. Clin. Chem. Lab. Med.: CCLM/FESCC. 2012;50:285–292. - PubMed
-
- Ekman R., Nilsson-Ehle P. Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin. Chim. Acta. 1975;63:29–35. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous